Chaoju Eye Care Holdings Limited (HKG:2219)

Market Cap	1.77B -5.9%
Revenue (ttm)	1.51B -3.2%
Net Income	204.14M -6.0%
EPS	0.29 -7.1%
Shares Out	692.94M
PE Ratio	8.85
Forward PE	7.38
Dividend	0.24 (9.50%)
Ex-Dividend Date	May 14, 2026

Volume	273,500
Open	2.560
Previous Close	2.550
Day's Range	2.530 - 2.580
52-Week Range	2.440 - 3.140
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Chaoju Eye Care Holdings

Chaoju Eye Care Holdings Limited, together with its subsidiaries, owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China. The company offers in-patient and out-patient ophthalmic medical services; and consumer ophthalmic services, including treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia prevention and control. It also provides basic ophthalmic services for the treatment of a range of eye diseases, including cataract, glaucoma, squint...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1988
• Employees: 2,590
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2219

Financial Performance

In 2025, Chaoju Eye Care Holdings's revenue was 1.36 billion, a decrease of -3.21% compared to the previous year's 1.41 billion. Earnings were 183.45 million, a decrease of -5.96%.

Financial numbers in CNY